TrialFind
Saved trials
Back to results
Unknown
Phase 2
A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer
NCT03691051
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Henan Cancer Hospital
Zhengzhou, Henan, China
View on ClinicalTrials.gov
Official details
A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer — TrialFind